Leica Biosystems and Sectra partner for FDA clearance of digital pathology solution

Leica Biosystems and Sectra announced a collaboration to seek a combined 510(k) clearance from the FDA for an integrated clinical digital pathology solution.

“Leica Biosystems and Sectra announce a collaboration to seek a combined 510(k) clearance from the U.S. Food & Drug Administration.”newswire.ca

• 1 source
• newswire.caLeica Biosystems and Sectra Partner to Pursue FDA Clearance for an Integrated Clinical Digital Pathology SolutionLeica BiosystemsDec 2, 2019

Summarized from public sources; check the original articles before acting on it.